Radiobinding assay

From Wikipedia, the free encyclopedia

A radiobinding assay is a method of detecting and quantifying antibodies targeted towards a specific antigen. As such, it can be seen as the inverse of radioimmunoassay, which quantifies an antigen by use of corresponding antibodies.

Technique

The corresponding antigen is radiolabeled and mixed with the fluid that may contain the antibody, such as blood serum from a person. Presence of antibodies cause precipitation of antibody-antigen complexes that can be collected by centrifugation into pellets. The amount of antibody is proportional to the radioactivity of the pellet, as determined by gamma counting.[1]

Uses

It is used to detect most autoantibodies seen in latent autoimmune diabetes.[2]

References

  1. ↑ Anti-dsDNA [I-125] Radiobinding Assay Kit At PerkinElmer Life Sciences, Inc. Retrieved Jan 2011
  2. ↑ Knip, M.; Veijola, R.; Virtanen, S. M.; Hyoty, H.; Vaarala, O.; Akerblom, H. K. (2005). "Environmental Triggers and Determinants of Type 1 Diabetes". Diabetes 54: S125–S136. doi:10.2337/diabetes.54.suppl_2.S125. PMID 16306330. 
Medical test: Immunologic techniques and tests (CPT 86000–86849)
Immunologic techniques
and tests
Other
Inflammation

M: LMC

cell/phys/auag/auab/comp, igrc

imdf/ipig/hyps/tumr

proc, drug (L3/4)


This article is issued from Wikipedia. The text is available under the Creative Commons Attribution/Share Alike; additional terms may apply for the media files.